Niagen Bioscience公司宣布,已成功获得一项新的美国专利,该专利涵盖了烟酰胺核苷的静脉注射制剂、注射制剂及其使用方法。这一专利的授予进一步巩固了该公司在相关技术领域的知识产权布局。
Niagen Bioscience公司宣布,已成功获得一项新的美国专利,该专利涵盖了烟酰胺核苷的静脉注射制剂、注射制剂及其使用方法。这一专利的授予进一步巩固了该公司在相关技术领域的知识产权布局。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.